Grant funding
Showing of 49 results
St. Baldrick’s Grant Awarded to UH Rainbow Physician Researcher for Pediatric Neuroblastoma Study
The grant will support Dr. John Letterio’s project titled, “Development of a Novel NF-κB Targeting Agent for Pediatric Neuroblastoma” focused on improving treatment outcomes for children with high-risk neuroblastoma.
C-Path’s Translational Therapeutics Accelerator Announces $200,000 Grant for Drug Development Project in Inflammatory Bowel Disease
University Hospitals Cleveland Medical Center physician awarded funding to advance novel therapy for IBD.
Harrington Discovery Institute Announces 2025 Scholar-Innovator Award Recipients
Drug development grant will advance 10 physician-scientists’ discoveries toward the clinic.
Harrington Discovery Institute Opens Call for 2026 Harrington Scholar-Innovator Award
Unique program for physician-scientists to advance promising discoveries into medicines.
UH Seidman Cancer Center Researcher Awarded New Gastrointestinal Cancer Grant from NCCN in Collaboration with Taiho Oncology, Inc.
Dr. Madison Conces was awarded for a Phase II Clinical Trial of Trifluridine/Tipiracil plus Oxaliplatin in Patients with Advanced or Metastatic Biliary Tract Cancer Following First-Line Therapy.
UH Rainbow Receives Grants from the Society of Critical Care Medicine to Study Severe Bronchiolitis
UH Rainbow Babies & Children’s Hospital has received two grants from SCCM to study the pathobiological factors and mechanistic underpinnings underlying severe bronchiolitis and sepsis.
Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.
Oxford-Harrington Rare Disease Centre Opens 2025 Call for Proposals
Scholar Award Accelerates Novel Therapies for Rare Diseases.